
Company valuation, historical trends, and peer comparisons.
According to Entia Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.00M. This represents a change of -54.66% compared to the average of 2.21M of the last 4 quarters.
The mean historical Enterprise Value of Entia Biosciences, Inc. over the last ten years is 4.77M. The current 1.00M Enterprise Value has changed -78.96% with respect to the historical average. Over the past ten years (40 quarters), ERGO's Enterprise Value was at its highest in in the March 2009 quarter at 27.97M. The Enterprise Value was at its lowest in in the April 2008 quarter at 0.
Average
4.77M
Median
3.77M
Minimum
0
Maximum
15.26M
Discovering the peaks and valleys of Entia Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 15.26M
Minimum Annual Increase = -54.05%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2016 | 2.55M | 4.28% |
| 2015 | 2.44M | 8.29% |
| 2014 | 2.25M | -54.05% |
| 2013 | 4.91M | 19.88% |
| 2012 | 4.09M | 18.78% |
| 2011 | 3.45M | -32.60% |
| 2010 | 5.11M | -33.18% |
| 2009 | 7.65M | -49.87% |
| 2008 | 15.26M | Infinity% |
The current Enterprise Value of Entia Biosciences, Inc. (ERGO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.41M
5-year avg
3.25M
10-year avg
4.77M
Entia Biosciences, Inc.’s Enterprise Value is greater than AVAX Technologies, Inc. (-5896313.00), less than DNAPrint Genomics, Inc. (6.70M), less than Statera Biopharma, Inc. (14.43M), less than RepliCel Life Sciences Inc. (1.92M), less than Biostax Corp. (1.12M), greater than Better Therapeutics, Inc. (-854548.00), greater than Panacos Pharmaceuticals, Inc. (-18548636.00), greater than South American Gold Corp. (411.91K), greater than WOWI, Inc. (83.38K), greater than Bangi Inc. (-21372.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -5896313.00 | $6.89K | |
| 6.70M | $12.89K | |
| 14.43M | $14.28K | |
| 1.92M | $7.36K | |
| 1.12M | $15.74K | |
| -854548.00 | $5.45K | |
| -18548636.00 | $5.36K | |
| 411.91K | $67.73K | |
| 83.38K | $3.38K | |
| -21372.00 | $5.25K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entia Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Entia Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Entia Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Entia Biosciences, Inc. (ERGO)?
What is the 3-year average Enterprise Value for Entia Biosciences, Inc. (ERGO)?
What is the 5-year average Enterprise Value for Entia Biosciences, Inc. (ERGO)?
How does the current Enterprise Value for Entia Biosciences, Inc. (ERGO) compare to its historical average?